Full text is available at the source.
Highlights on U.S. FDA-approved fluorinated drugs over the past five years (2018–2022)
Summary of FDA-Approved Fluorinated Drugs in the U.S. from 2018 to 2022
AI simplified
Abstract
The U.S. Food and Drug Administration approved a total of fifty-eight fluorinated drugs from 2018 to 2022.
- Thirty of the approved drugs are intended for the treatment of various types of cancers.
- Twelve drugs are aimed at addressing infectious diseases.
- Eleven fluorinated drugs are developed for central nervous system disorders.
- Six additional drugs are categorized for other types of diseases.
- The review includes details on trade names, approval dates, active ingredients, developers, indications, and drug mechanisms.
AI simplified